Hong Kong Stock Exchange latest filings reveal a significant change in the share depository position for SISRAM MED (01696) on July 23. The total market value of the deposited shares reached HK$530 million, representing 46.23% of the company's total issued shares.
A shareholder of the company has deposited 217 million shares into UBS Securities Hong Kong, increasing their shareholding proportion by 46.24%.
The financial results of SISRAM MED for the year ended December 31, 2025, show that the group achieved revenue of US$365 million during the period, a year-on-year increase of 4.7%. Profit attributable to owners of the parent company was US$19.016 million, a decrease of 24.32% compared to the previous year. Basic earnings per share were 4.06 US cents. The company has proposed a final dividend of HK$0.095 per share.